Wiley (WLY) 2026 Earnings Outlook, Strategy, and Analysis
As Wiley (WLY) gears up for its 2026 earnings, investors should focus on segment growth, margin trajectory, and the c...
Volatility Index Funds Vs Bonds In Retirement
Analyze how volatility differs between index funds and bonds in retirement, and craft a plan that moderates swings while pursuing growth.
23,614 articles
Next Test for Master-Planned Communities: Staying Power
As mortgage rates wobble and demand shifts, master planned communities are being judged on staying power rather than ...
Memory Stocks Exploded 1,000% as AI Demand Surges Globally
Memory stocks exploded 1,000% last year as AI demand surged. Analysts say silver and copper could be next AI benefici...
Cramer Watching Marvell After Huang Calls It Trillion-Dollar Stock
Jim Cramer says he is watching Marvell after Jensen Huang’s trillion-dollar endorsement, making the AI hardware name ...
Technologies Director Sells $287,000: What Investors Should Know
Insider moves can reveal a lot about a company's near-term strategy, but they rarely tell the whole story. This guide...
What 50-Year-Old Letter Says About Homebuilding Accountability
A 50-year-old handwritten letter reappears, offering a timeless view on accountability in homebuilding and how borrow...
Hype Signals Fade: Wins Looking More Like Exceptions
A wave of selective rallies in WLD, XLM, and JTO underscores a fragile altcoin bounce. Analysts say hype is waning, w...
Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Forget Speed: L’Oréal’s Innovation Strategy Reshapes AI
L’Oréal’s innovation chief says speed isn’t enough in AI-driven markets; enduring success comes from history, structu...
Intel’s Surge Apple Chip Sparks Foundry Bets, Analysts Say
Stocks surged on unconfirmed chatter of an Apple chip deal with Intel, fueling bets on Intel’s foundry business. Anal...
Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Netflix Will Trade This Level by 2028, Analysts Say
Netflix faces a pivotal 2026-27 as ad revenue and free cash flow rise. Analysts sketch a path to roughly $300 by 2028...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status